BE858134A - Nouveaux derives de 0-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques - Google Patents

Nouveaux derives de 0-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques

Info

Publication number
BE858134A
BE858134A BE180447A BE180447A BE858134A BE 858134 A BE858134 A BE 858134A BE 180447 A BE180447 A BE 180447A BE 180447 A BE180447 A BE 180447A BE 858134 A BE858134 A BE 858134A
Authority
BE
Belgium
Prior art keywords
propyl
hydroxy
amino
preparation
new
Prior art date
Application number
BE180447A
Other languages
English (en)
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of BE858134A publication Critical patent/BE858134A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
BE180447A 1976-08-27 1977-08-26 Nouveaux derives de 0-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques BE858134A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives

Publications (1)

Publication Number Publication Date
BE858134A true BE858134A (fr) 1977-12-16

Family

ID=10994625

Family Applications (1)

Application Number Title Priority Date Filing Date
BE180447A BE858134A (fr) 1976-08-27 1977-08-26 Nouveaux derives de 0-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques

Country Status (23)

Country Link
JP (1) JPS5350131A (fr)
AT (1) AT355554B (fr)
AU (1) AU521432B2 (fr)
BE (1) BE858134A (fr)
CA (1) CA1077506A (fr)
CH (1) CH630344A5 (fr)
CS (1) CS204008B2 (fr)
DD (1) DD132433A5 (fr)
DE (1) DE2738589A1 (fr)
DK (1) DK150196C (fr)
ES (1) ES462346A1 (fr)
FI (1) FI68396C (fr)
FR (1) FR2362845A1 (fr)
GB (1) GB1582029A (fr)
GR (1) GR63623B (fr)
HU (1) HU177578B (fr)
IL (1) IL52804A (fr)
NL (1) NL187478C (fr)
NO (1) NO144793C (fr)
PL (1) PL107628B1 (fr)
SE (1) SE435280B (fr)
SU (1) SU730296A3 (fr)
YU (2) YU202377A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
JPH01169445A (ja) * 1987-12-25 1989-07-04 Fuji Photo Film Co Ltd 焦点距離切換えカメラ
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
HU222994B1 (hu) 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
US6251926B1 (en) 1998-05-11 2001-06-26 Takeda Chemical Industries, Ltd. Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
WO2000007580A2 (fr) * 1998-08-03 2000-02-17 N-Gene Kutató Kft. Compositions pharmaceutiques de lutte contre les maladies auto-immunes
IL162941A0 (en) 2002-01-11 2005-11-20 Biorex Kutato Fejlesztoe Kft Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
MX2023005954A (es) 2020-11-19 2023-09-04 Zevra Denmark As Procesos para preparar citrato de arimoclomol e intermediarios del mismo.

Also Published As

Publication number Publication date
ATA605477A (de) 1979-08-15
FR2362845A1 (fr) 1978-03-24
FI68396B (fi) 1985-05-31
IL52804A0 (en) 1977-10-31
NO144793C (no) 1981-11-11
JPS6216942B2 (fr) 1987-04-15
NO772958L (no) 1978-02-28
DK150196B (da) 1987-01-05
FI772551A (fi) 1978-02-28
ES462346A1 (es) 1978-06-16
SE435280B (sv) 1984-09-17
AU521432B2 (en) 1982-04-01
JPS5350131A (en) 1978-05-08
SU730296A3 (ru) 1980-04-25
NO144793B (no) 1981-08-03
DD132433A5 (de) 1978-09-27
HU177578B (en) 1981-11-28
GB1582029A (en) 1980-12-31
CA1077506A (fr) 1980-05-13
DE2738589A1 (de) 1978-03-02
NL187478C (nl) 1991-10-16
AU2825477A (en) 1979-03-01
FR2362845B1 (fr) 1981-01-09
CS204008B2 (en) 1981-03-31
YU202377A (en) 1983-12-31
AT355554B (de) 1980-03-10
DK379777A (da) 1978-02-28
IL52804A (en) 1981-06-29
PL107628B1 (pl) 1980-02-29
YU237782A (en) 1983-12-31
NL7709276A (nl) 1978-03-01
GR63623B (en) 1979-11-27
FI68396C (fi) 1985-09-10
SE7709482L (sv) 1978-02-28
DK150196C (da) 1987-07-06
CH630344A5 (en) 1982-06-15

Similar Documents

Publication Publication Date Title
FR2338271A1 (fr) Derives du phtalane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives
BE855032A (fr) Compositions pharmaceutiques pour opacification barytee et leur procede de preparation
FR2306703A1 (fr) Nouveaux derives d'erythromycine, procede pour leur preparation et medicaments les renfermant
BE885385A (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant
MC1316A1 (fr) Ion nouveaux derives de flavone et procede pour leur preparat0
BE858134A (fr) Nouveaux derives de 0-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques
BE862870A (fr) Nouveaux derives steroides 11 beta-substitues 1,3,5(10)-trieniques, procede de preparation et compositions pharmaceutiques
BE857138A (fr) Derives peptidiques, procede pour leur preparation et compositions therapeutiques contenant ces composes
BE869605A (fr) Nouveaux derives de la diphenoxy-1,3 propanone-2, procede pour leur preparation et leur utilisation dans des compositions pharmaceutiques
BE884083A (fr) Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant
FR2539126B1 (fr) Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant
BE827444A (fr) Nouveaux derives de la thyronamine, procede de preparation et compositions pharmaceutiques
FR2317930A1 (fr) Nouveaux derives d'apovincaminol, leur procede de preparation et leur application
FR2281366A1 (fr) Ureylene-thiophanes et leurs derives, et procede pour leur preparation
BE832983A (fr) Cycloalkyl-13, 14-deshydro-protaglandines et procede pour leur preparation
BE885633A (fr) Derives de 1,2,4-oxadiazolin-5-one, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2347338A1 (fr) Nouveaux derives dipeptidiques, leur procede de preparation et compositions pharmaceutiques les contenant
BE851681A (fr) 2,9-dioxatricyclo-4,3,03,7- decanes et procede pour leur preparation
BE875091A (fr) Derives de substitution de spirooxazolidinone steroidienne, leur procede de preparation et compositions pharmaceutiques les contenant
FR2274307A1 (fr) Nouveaux derives hexahydro-diazepino-indoliques et procede pour leur preparation
BE833489A (fr) Nouveaux derives steroides, procede de preparation et compositions pharmaceutiques
BE869834A (fr) Nouveaux derives de 3-amino-17a-aza-d-homo-androstane, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2314720A1 (fr) Nouveaux derives de cephalosporines, leurs intermediaires et procede pour leur preparation
BE861137A (fr) Ortho-aminoacetophenones utiles comme medicaments et procede pour leur preparation
BE871824A (fr) Nouveaux derives steroides 17 alpha-aryle, leur procede de preparation et les compositions pharmaceutiques les renfermant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT

Effective date: 19960831